REGULATORY

MHLW Gives Fuel Priority to Drug Deliveries in Quake-Hit Kumamoto

August 4, 2026

Identification Pass for Priority Refueling
Identification Pass for Priority Refueling

Japan’s Ministry of Health, Labor and Welfare (MHLW) has introduced a priority fuel supply scheme for vehicles delivering pharmaceuticals and medical devices in areas affected by the Kumamoto earthquake.

The MHLW issued an administrative communication on July 31 after receiving reports that shortages of gasoline and diesel fuel were disrupting deliveries to medical institutions, pharmacies, and evacuation centers in the disaster zone. The ministry said the measure was rolled out in coordination with the Ministry of Economy, Trade and Industry (METI).

Under the scheme, eligible organizations, including the Federation of Japan Pharmaceutical Wholesalers Association (JPWA), must submit vehicle and route information to the MHLW in advance. Registered vehicles presenting the administrative communication and an official identification pass will receive priority refueling at designated service stations operated under METI’s emergency fuel supply network.

Related Article

REGULATORY

Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…

By Philip Carrigan

The Wednesday TableShe had been on virtual calls since eight in the morning. The screen glowed. Her eyes burned. Plugged into Teams across time zones, she was digitally connected yet entirely isolated from the reality of Japan’s pharma market.She needed…

By Shinya Sato

The development of Boehringer Ingelheim’s survodutide is gathering pace, putting the GLP-1/glucagon receptor agonist in contention to become the next…

Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…

By Ken Yoshino

The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…

The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…

Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…

Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…